• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Epidermolysis Bullosa

Epidermolysis Bullosa - 53 Studies Found

Not yet recruiting : Diacerin for the Treatment of Epidermolysis Bullosa Simplex
: Epidermolysis Bullosa Simplex
: 2015-05-27
: Drug: Diacerin cream Diacerin tablet solubule in ultraphil cream
Completed : Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa
: Epidermolysis Bullosa With Mitten Hands
: 2013-07-23
: Biological: Cell transplantation autologous transplantation of cultured fibroblast on amniotic membrane
Completed : Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
: Epidermolysis Bullosa Acquisita
: 1999-10-18
: Drug: methoxsalen
Not yet recruiting : Safety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS)
: Epidermolysis Bullosa Simplex
: 2017-05-10
:
  • Drug: Diacerein 1% Ointment Topical Formulation

Completed : Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
: Epidermolysis Bullosa Simplex
: 2009-07-08
:
  • Drug: Dysport® (Botulinumtoxin A (Btx A))

Completed : Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
:
  • Epidermolysis Bullosa Simplex
  • Pachyonychia Congenita

: 2015-10-29
:
  • Drug: Jojoba oil with broccoli sprout extract

Completed : A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare� Matrix) for Wound Healing in RDEB Patients
: Recessive Dystrophic Epidermolysis Bullosa
: 2025-08-06
: The Spincare device, developed by Nanomedic, is the first portable tool that delivers a non-invasive, non-therapeutic electrospun, nanofibrous matrix
Completed : Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
: Epidermolysis Bullosa
: 2025-08-06
: Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs)
NOT_YET_RECRUITING : Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
: Dystrophic Epidermolysis Bullosa
: 2025-08-06
: poloxamer hydrogel for topical administration
Completed : EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
: Epidermolysis Bullosa
: 2025-08-06
: EB-101 autologous RDEB keratinocytes isolated from skin biopsies and transduced with a recombinant retrovirus containing a full-length COL7A1 expre
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.